Page 13 - วารสารกรมการแพทย์แผนไทยฯ ปีที่ 11 ฉบับที่ 1
P. 13

Journal of Thai Traditional & Alternative Medicine   Vol. 11 No. 1 January-April 2013  7



                                                                                      23
              π“∑’ ´÷ËßπâÕ¬°«à“°≈ÿࡧ«∫§ÿ¡ „π¢≥–∑’Ëæƒμ‘°√√¡  (IC  =10.64 ± 2.09 ‰¡‚§√‚¡≈“√å)
                                                            50
              ∑“߇滥â“πÕ◊ËπÊ ‰¡à·μ°μà“ß°—π (frequency, in-      1.5 º≈μàÕ√–∫∫ ◊∫æ—π∏ÿå‡æ»™“¬°“√ ÿà¡
              tromission frequency, mount latency À√◊Õ in-  ∑¥≈Õß„πÀπŸ·√μ‡æ»ºŸâ ·∫à߇ªìπ 2 °≈ÿࡧ◊Õ°≈ÿà¡
              tromission latency) ·≈–®“°°“√»÷°…“§«“¡‡ªìπ  §«∫§ÿ¡·≈–°≈ÿà¡∑’Ë„Àâ°√–™“¬¥” 1,000 ¡°./°°./«—π

              æ‘…æ∫«à“ ‰¡à¡’§«“¡·μ°μà“ߢÕߌ’‚¡‚°≈∫‘π, ‡¡Á¥  ‚¥¬„Àâ∑“ߪ“° ‡ªìπ‡«≈“ 45 «—π æ∫«à“°√–™“¬¥”
              ‡≈◊Õ¥¢“« ·≈–‰¡à¡’º≈μàÕ‰μ, μ—∫, §à“ blood urea  ∑”„ÀâπÈ”Àπ—°μ—«‡æ‘Ë¡¢÷Èπ‡¡◊ËÕ‡ª√’¬∫‡∑’¬∫°—∫°≈ÿà¡
              nitrogen, creatinine, aspartate aminotrans-  §«∫§ÿ¡ ·μà‰¡à¡’§«“¡·μ°μà“ߢÕßπÈ”Àπ—°¢Õß

              ferase ·≈– alanine aminotransferase ·μஓ°  Õ«—¬«– ◊∫æ—π∏ÿå (Õ—≥±–, seminal vesicle plus
              °“√»÷°…“∑“ß®ÿ≈欓∏‘«‘∑¬“æ∫«à“ ¡’°“√‡ª≈’ˬπ·ª≈ß  coagulating gland, levator ani muscle plus

              ∑“ß —≥∞“π«‘∑¬“„πμ—∫  √ÿª‰¥â«à“ “√ °—¥°√–™“¬  bulbocarvernosus muscle ·≈– glans penis,
              ¥”∑’Ë 240 ¡°./°°. ≈¥‡«≈“„π°“√®—∫§Ÿà¢ÕßÀπŸ„π 10  ¬°‡«âπμàÕ¡≈Ÿ°À¡“°), ‰μ, μàÕ¡À¡«°‰μ, gastrac-
              π“∑’·√° ·≈–‰¡à‡À¡“– ¡‡¡◊ËÕ„™â°—∫§π„πª√‘¡“≥ Ÿß  nemius muscle, √–¥—∫ follicle stimulating hor-
                                  21
              ·≈–μ‘¥μàÕ°—π‡ªìπ‡«≈“π“π                    mone, luteinizing hormone ·≈–æƒμ‘°√√¡
                     1.3 ƒ∑∏‘ϧ≈“¬°“√°≈â“¡‡π◊ÈÕ cavernosum  °“√®—∫§Ÿà ·μà√–¥—∫¢Õß testosterone ·≈– pro-

              ∑’Ë penis ®“°°“√»÷°…“„π isolated human     gesterone ≈¥≈߇¡◊ËÕ„Àâ°√–™“¬¥” 30 «—π √–¥—∫ cor-
              cavernosum æ∫«à“ “√ 3, 5, 7, 3', 4'-penta-  ticosterone ≈¥≈ß„π 20 «—π·≈– 30 «—π  √ÿª
              methoxyflavone „π‡Àßâ“°√–™“¬¥” ¡’°≈‰°°“√   ‰¥â«à“°√–™“¬¥”‰¡à¡’º≈√∫°«πμàÕ hypothalamic-

              ÕÕ°ƒ∑∏‘ϧ≈“¬°“√°≈â“¡‡π◊ÈÕ cavernosum ·μ°   pituitary-testicular axis À√◊Õ√–∫∫ ◊∫æ—π∏ÿå‡æ»
                                                            24
              μà“ß®“° sildenafil ´÷Ë߇ªìπ phosphodiesterase  ™“¬
              inhibitor ‚¥¬ÕÕ°ƒ∑∏‘Ϻà“π voltage-dependent     °“√ ÿà¡∑¥≈Õß„πÀπŸ·√μ‰¡à‡μÁ¡«—¬∑’Ë∂Ÿ° cas-

                2+
              Ca  channels ·≈–°≈‰°Õ◊Ëπ∑’ˇ°’ˬ«¢âÕß°—∫ calcium  trated ‚¥¬·∫à߇ªìπ 2 °≈ÿࡧ◊Õ°≈ÿࡧ«∫§ÿ¡·≈–
              mobilization ¡’ƒ∑∏‘ÏÕàÕπ„π°“√∑”„À⇰‘¥°“√À≈—Ëß  °≈ÿà¡∑’Ë„Àâ°√–™“¬¥” 1,000 ¡°./°°. ‚¥¬„Àâ∑“ߪ“°
              nitric oxide ·≈–‰¡à¡’ƒ∑∏‘χªìπ phosphodiesterase  »÷°…“¥â«¬«‘∏’ Hershberger assay ‡ªìπ‡«≈“ 5 «—π
                     22
              inhibitor                                  æ∫«à“°≈ÿà¡∑’ˉ¥â√—∫°√–™“¬¥”¡’πÈ”Àπ—°μ—«‡æ‘Ë¡¢÷Èπ„π 24
                     1.4 º≈μàÕ‡Õπ‰´¡å phosphodiesterase  ·≈– 48 ™—Ë«‚¡ßÀ≈—ß„Àâ§√—Èß·√° (P<0.05) À≈—ß®“°

              type 5 (PDE5) ∑¥≈Õß·¬° “√®“°‡Àßâ“°√–™“¬¥”  π—Èπæ∫«à“‰¡à·μ°μà“ß®“°°≈ÿࡧ«∫§ÿ¡ ·≈–‰¡à¡’
              ¥â«¬«‘∏’ two-step radioactive assay æ∫«à“ “√ °—¥  §«“¡·μ°μà“ߢÕßπÈ”Àπ—°¢ÕßÕ«—¬«– ◊∫æ—π∏ÿå, ‰¡à„™à
              50  μg/ml ¡’ƒ∑∏‘Ϭ—∫¬—È߇Õπ‰´¡å PDE5 ·≈–   Õ«—¬«– ◊∫æ—π∏ÿå, √–¥—∫ FSH, LH, progesterone À√◊Õ

               “√ª√–°Õ∫ 7-methoxyflavone 10 ‰¡‚§√‚¡≈“√å  corticosterone √–À«à“ß°≈ÿà¡ „π¢≥–∑’Ë glans
              ¡’ƒ∑∏‘Ϭ—∫¬—Èß∑—Èß PDE5 (‡μ√’¬¡®“°ªÕ¥ÀπŸ‰¡´å) ·≈–  penis, √–¥—∫ testosterone ·≈– progesterone

              PDE6 (‡μ√’¬¡®“°‡√μ‘𓉰à)  “√∑’Ë¡’ƒ∑∏‘Ï·√ß∑’Ë ÿ¥  ¡’·π«‚π⡇æ‘Ë¡¢÷Èπ ·μà LH ≈¥≈ß„π°≈ÿà¡∑’Ë„Àâ
              „π°“√¬—∫¬—Èß PDE5 §◊Õ 5,7-dimethoxyflavone  °√–™“¬¥”  √ÿª‰¥â«à“°√–™“¬¥”‰¡à¡’º≈μàÕ√–∫∫
   8   9   10   11   12   13   14   15   16   17   18